Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Businessweek Archives

Transatlantic Drugmakers Team Up


In Business This Week

TRANSATLANTIC DRUGMAKERS TEAM UP

The battle among drug companies for over-the-counter shelf space is heating up. On July 28, British drugmakers Glaxo Holdings and Wellcome announced separate plans to team up with Warner-Lambert. Glaxo and Warner-Lambert plan to form a joint venture aimed at developing and marketing a version of Glaxo's $3.2 billion ulcer drug, Zantac. Wellcome and Warner-Lambert have established a partnership that will do the same for a version of Wellcome's $1 billion antiviral medication,Zovirax.

The British companies are hoping that Warner-Lambert's marketing muscle can help stave off share erosion as patent expiration--and generic competition--loom for Zovirax and Zantac.

News on Wellcome's AIDS drug, AZT: A North Carolina court recently upheld the company's exclusive patent rights, effectively barring two U.S. rivals from selling generic clones. EDITED BY KEITH H. HAMMONDS


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus